Publication | Closed Access

An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease

Neurodegenerative DiseasesSignal TransductionAlzheimer's DiseaseSignaling PathwayMedicineCell DeathDegenerative PathologyPharmacologyCell BiologyCell SignalingTau HyperphosphorylationProtective Mechanisms